Earnings Per Share - Schedule of Net Income (Loss) Per Share-Diluted Including Anti-Dilutive (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Stock options outstanding to purchase shares of common stock [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Stock options outstanding to purchase shares of common stock | 4,145,706 | |
| Public and Private Warrants [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Stock options outstanding to purchase shares of common stock | 11,799,851 | |
| Earn-Out Liability [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Stock options outstanding to purchase shares of common stock | 4,500,000 | |